418 results on '"Biava, Mariangela"'
Search Results
2. Contributors
3. Natural Flavonoid and Chalcone Scaffolds as Leads for Synthetic Antitubercular Agents
4. SAR Analysis of Novel Coxsackie virus A9 Capsid Binders.
5. Amino Acid Biosynthesis Inhibitors in Tuberculosis Drug Discovery
6. 6-Fluorophenylbenzohydrazides inhibit Mycobacterium tuberculosis growth through alteration of tryptophan biosynthesis
7. Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy
8. Therapeutic potential for coxibs-nitric oxide releasing hybrids in cystic fibrosis
9. Transmission-Blocking Strategies for Malaria Eradication: Recent Advances in Small-Molecule Drug Development.
10. Mycobacterial tryptophan biosynthesis: A promising target for tuberculosis drug development?
11. In vitro comprehensive analysis of VA692 a new chemical entity for the treatment of osteoarthritis
12. In vivo potent BM635 analogue with improved drug-like properties
13. Pharmaceutical salt of BM635 with improved bioavailability
14. Development of MmpL3 inhibitors for tuberculosis treatment
15. (E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors
16. Antiviral Mechanisms of N-Phenyl Benzamides on Coxsackie Virus A9
17. Direct-Acting Antivirals and Host-Targeting Approaches against Enterovirus B Infections: Recent Advances
18. Chondroprotective effect of three different classes of anti-inflammatory agents on human osteoarthritic chondrocytes exposed to IL-1β
19. Synthesis, biological evaluation and docking analysis of a new series of methylsulfonyl and sulfamoyl acetamides and ethyl acetates as potent COX-2 inhibitors
20. 1,5-Diarylpyrroles as potent antitubercular and anti-inflammatory agents
21. SAR analysis of new anti-TB drugs currently in pre-clinical and clinical development
22. Chapter 3 - Therapeutic potential for coxib-nitric oxide releasing hybrids in cancer treatment
23. Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors
24. A class of pyrrole derivatives endowed with analgesic/anti-inflammatory activity
25. Antiproliferative effect of two novel COX-2 inhibitors on human keratinocytes
26. 1,5-Diphenylpenta-2,4-dien-1-ones as potent and selective monoamine oxidase-B inhibitors
27. Improving the solubility of a new class of antiinflammatory pharmacodynamic hybrids, that release nitric oxide and inhibit cycloxygenase-2 isoenzyme
28. Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis
29. In Vitro Effects of VA441, a New Selective Cyclooxygenase-2 Inhibitor, on Human Osteoarthritic Chondrocytes exposed to IL-1β
30. Malaria transmission blocking compounds: a patent review
31. Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment
32. Identification of a novel pyrrole derivative endowed with antimycobacterial activity and protection index comparable to that of the current antitubercular drugs streptomycin and rifampin
33. A Novel Class of Dual-Acting DCH-CORMs Counteracts Oxidative Stress-Induced Inflammation in Human Primary Tenocytes
34. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies
35. Metabolomic Profiling of Fresh Goji (Lycium barbarum L.) Berries from Two Cultivars Grown in Central Italy: A Multi-Methodological Approach
36. Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents
37. Chapter Three - Development of MmpL3 inhibitors for tuberculosis treatment
38. Overcoming drug resistance in TB: an update
39. SAR Analysis of Small Molecules Interfering with Energy-Metabolism in Mycobacterium tuberculosis
40. Antimycobacterial compounds. Optimization of the BM 212 structure, the lead compound for a new pyrrole derivative class
41. Antimycobacterial compounds. New pyrrole derivatives of BM212
42. Importance of the thiomorpholine introduction in new pyrrole derivatives as antimycobacterial agents analogues of BM 212
43. Chocolate Consumers and Lymphocyte-to-Monocyte Ratio: A Working Hypothesis from a Preliminary Report of a Pilot Study in Celiac Subjects
44. Novel Pyrazole-Containing Compounds Active against Mycobacterium tuberculosis
45. Meet Our Editorial Board Member
46. Neutrophil-to-Lymphocyte Ratio, Mediterranean Diet, and Bone Health in Coeliac Disease Patients: A Pilot Study
47. Synthesis and biological evaluation of fluorinated 1,5-diarylpyrrole-3-alkoxyethyl ether derivatives as selective COX-2 inhibitors endowed with anti-inflammatory activity
48. Meet Our Editorial Board Member
49. Introduction to COX inhibitors
50. New pyrrole derivatives as antimycobacterial agents analogs of BM212
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.